Kratom is increasing in popularity – here is the 411 on what to know. Curious about high-potency Kratom, you’re not alone. There are many vendors offering high-potency kratom: what you need to know if ...

The high-potency cannabis that is now widely available may raise the risk of both psychosis and addiction, a report published Monday in The Lancet Psychiatry finds. The potency of cannabis — measured ...

Back in 2019 when hemp was newly legal throughout the country, CBD became the Next Big Thing in the world of natural wellness products. And little wonder: when cannabis was still illegal in many ...

While cannabis may be legal in Minnesota, it’s still important to be aware of the risks associated with it, especially with high-potency products on the brains of those under 25. “It’s different from ...

HIGHLANDS RANCH, Colorado — A Colorado mother is on a mission to educate the public about the detrimental impacts of THC on brain health in teenagers. Laura Stack's son Johnny took his own life after ...

A new study suggests people who consume cannabis that has a THC concentration of 10% or higher are also more likely to be dependent on the substance and have anxiety. The study researchers suggested ...

Our oldest child started using high-potency marijuana at age 14. He got it from his friend’s older brother. His discovery has had a profound impact on his life and our family. Three years later, he ...

OLYMPIA, Wash. — The Washington state Senate overwhelmingly approved legislation that calls for public education and warnings about potential dangers of high-potency cannabis products. House Bill 2320 ...

Just 20 years ago levels of tetrahydracannabinol, the compound in cannabis known as THC that makes you high, was between 2% and 4% in most marijuana. By 2013, common strains contained 25% THC, with ...

Legalization of marijuana, both for medical and recreational use, continues to spread across the globe even as the possible health risks (or benefits) are not fully known. Case in point, according to ...

Less than half of patients with acute coronary syndromes are treated with high-potency statins, with individuals who stand the benefit most from treatment less likely to receive these lipid-lowering ...